Adverse cardiological and neurological reactions associated with air traffic and the possibility of their pharmacological correction

Air transport may provoke or aggravate a medical event in a passenger with concomitant medical problems. We searched the PubMed and Scopus databases for the period up to 08/29/2024 for sources that examined the impact of air travel on human health. There are 2 main categories of stressors associated with air travel and affecting the body, generally divided into: (1) psychological and physical stressors and (2) physiological Possible changes in health associated with air travel can be divided into functional, mostly reversible, and organic: (1) exacerbation/decompensation of existing somatic pathology; (2) development of pathological conditions de novo, for which possible stressors can serve as a trigger, directly or sequentially as a result of the previous development and progression of functional disorders. The literature focuses on safety issues during air travel for patients with existing cardiovascular pathology. Adverse functional cardiological and neurological reactions and their pharmacological correction have been less studied. Fear of flying and phobia of flying are very common among the general population and can lead to significant stress. For situational correction of reactions to everyday stressful events, it is possible to use drugs with anxiolytic action of a non-benzodiazepine This group includes the drug Valocordin®, the action of which is aimed at various manifestations of stress, anxiety states, autonomic dysfunction, increased excitability and irritability, mild sleep disorders. In case of pre-flight anxiety and fear, taking Valocordin® (depending on the situation or in a short course) can be the drug of choice for both the air traveler and his relatives seeing him off/meeting him.